ZA892645B - 2-substituted-4-substituted-1,3-dioxolanes,synthesis and use thereof - Google Patents
2-substituted-4-substituted-1,3-dioxolanes,synthesis and use thereofInfo
- Publication number
- ZA892645B ZA892645B ZA892645A ZA892645A ZA892645B ZA 892645 B ZA892645 B ZA 892645B ZA 892645 A ZA892645 A ZA 892645A ZA 892645 A ZA892645 A ZA 892645A ZA 892645 B ZA892645 B ZA 892645B
- Authority
- ZA
- South Africa
- Prior art keywords
- substituted
- dioxolanes
- synthesis
- particularly useful
- antiviral agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Secondary Cells (AREA)
- Furan Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Peptides Or Proteins (AREA)
- Paints Or Removers (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17961588A | 1988-04-11 | 1988-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA892645B true ZA892645B (en) | 1989-12-27 |
Family
ID=22657287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA892645A ZA892645B (en) | 1988-04-11 | 1989-04-11 | 2-substituted-4-substituted-1,3-dioxolanes,synthesis and use thereof |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0337713B1 (xx) |
JP (1) | JP3085675B2 (xx) |
KR (1) | KR0137023B1 (xx) |
AT (1) | ATE129247T1 (xx) |
AU (1) | AU631786B2 (xx) |
CA (1) | CA1339609C (xx) |
DE (1) | DE68924549T2 (xx) |
DK (1) | DK175372B1 (xx) |
ES (1) | ES2078234T3 (xx) |
GR (1) | GR3017812T3 (xx) |
HK (1) | HK5996A (xx) |
IE (1) | IE71225B1 (xx) |
IL (1) | IL89921A (xx) |
NZ (1) | NZ228645A (xx) |
OA (1) | OA09470A (xx) |
ZA (1) | ZA892645B (xx) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5597824A (en) * | 1987-11-03 | 1997-01-28 | Abbott Laboratories | Analogs of oxetanyl purines and pyrimidines |
US6350753B1 (en) | 1988-04-11 | 2002-02-26 | Biochem Pharma Inc. | 2-Substituted-4-substituted-1,3-dioxolanes and use thereof |
US6903224B2 (en) | 1988-04-11 | 2005-06-07 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes |
US6175008B1 (en) | 1988-04-11 | 2001-01-16 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
US7119202B1 (en) | 1989-02-08 | 2006-10-10 | Glaxo Wellcome Inc. | Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties |
US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
US5466806A (en) * | 1989-02-08 | 1995-11-14 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
US5270315A (en) * | 1988-04-11 | 1993-12-14 | Biochem Pharma Inc. | 4-(purinyl bases)-substituted-1,3-dioxlanes |
US5041449A (en) * | 1988-04-11 | 1991-08-20 | Iaf Biochem International, Inc. | 4-(nucleoside base)-substituted-1,3-dioxolanes useful for treatment of retroviral infections |
UA45942A (uk) * | 1989-02-08 | 2002-05-15 | Біокем Фарма, Інк. | 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція |
IE904378A1 (en) | 1989-12-20 | 1991-07-03 | Abbott Lab | Analogs of oxetanyl purines and pyrimidines |
US6642245B1 (en) | 1990-02-01 | 2003-11-04 | Emory University | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
US5728575A (en) | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
US5276151A (en) * | 1990-02-01 | 1994-01-04 | Emory University | Method of synthesis of 1,3-dioxolane nucleosides |
US6703396B1 (en) | 1990-02-01 | 2004-03-09 | Emory University | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
GB9009861D0 (en) * | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
ATE143016T1 (de) * | 1990-11-13 | 1996-10-15 | Iaf Biochem Int | Substituierte 1,3-oxathiolane mit antiviralen eigenschaften |
US5587480A (en) * | 1990-11-13 | 1996-12-24 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
US6228860B1 (en) | 1990-11-13 | 2001-05-08 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
US6369066B1 (en) | 1990-11-13 | 2002-04-09 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
US5925643A (en) * | 1990-12-05 | 1999-07-20 | Emory University | Enantiomerically pure β-D-dioxolane-nucleosides |
US5444063A (en) * | 1990-12-05 | 1995-08-22 | Emory University | Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity |
US5179104A (en) * | 1990-12-05 | 1993-01-12 | University Of Georgia Research Foundation, Inc. | Process for the preparation of enantiomerically pure β-D-(-)-dioxolane-nucleosides |
US5248776A (en) * | 1990-12-05 | 1993-09-28 | University Of Georgia Research Foundation, Inc. | Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides |
US6812233B1 (en) | 1991-03-06 | 2004-11-02 | Emory University | Therapeutic nucleosides |
GB9104740D0 (en) * | 1991-03-06 | 1991-04-17 | Wellcome Found | Antiviral nucleoside combination |
US5817667A (en) * | 1991-04-17 | 1998-10-06 | University Of Georgia Research Foudation | Compounds and methods for the treatment of cancer |
ZA923640B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
US6005107A (en) * | 1992-12-23 | 1999-12-21 | Biochem Pharma, Inc. | Antiviral compounds |
US6444656B1 (en) | 1992-12-23 | 2002-09-03 | Biochem Pharma, Inc. | Antiviral phosphonate nucleotides |
GB9226879D0 (en) * | 1992-12-23 | 1993-02-17 | Iaf Biochem Int | Anti-viral compounds |
CA2171550C (en) | 1993-09-10 | 2008-08-26 | Raymond F. Schinazi | Nucleosides with anti-hepatitis b virus activity |
US20020120130A1 (en) | 1993-09-10 | 2002-08-29 | Gilles Gosselin | 2' or 3' -deoxy and 2', 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti- viral agents |
US5587362A (en) * | 1994-01-28 | 1996-12-24 | Univ. Of Ga Research Foundation | L-nucleosides |
IL115156A (en) * | 1994-09-06 | 2000-07-16 | Univ Georgia | Pharmaceutical compositions for the treatment of cancer comprising 1-(2-hydroxymethyl-1,3-dioxolan-4-yl) cytosines |
US5703058A (en) * | 1995-01-27 | 1997-12-30 | Emory University | Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent |
US6391859B1 (en) | 1995-01-27 | 2002-05-21 | Emory University | [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides |
US5808040A (en) * | 1995-01-30 | 1998-09-15 | Yale University | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides |
ES2276404T3 (es) | 1995-06-07 | 2007-06-16 | Emory University | Nucleosidos con actividad antivirus de la hepatitis-b. |
US5753789A (en) * | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
US5792773A (en) * | 1996-11-15 | 1998-08-11 | Yale University | L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection |
US6022876A (en) * | 1996-11-15 | 2000-02-08 | Yale University | L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections |
WO1998041522A1 (en) | 1997-03-19 | 1998-09-24 | Emory University | Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides |
EP1754710A3 (en) | 1998-02-25 | 2007-12-19 | Emory University | 2'-Fluoroncucleosides |
EA008609B1 (ru) | 1998-02-25 | 2007-06-29 | Эмори Юниверсити | 2'-фторнуклеозиды |
ES2232169T3 (es) | 1998-08-12 | 2005-05-16 | Gilead Sciences, Inc. | Procedimiento de fabricacion de nucleosidos de 1,3-oxatiolano. |
US6979561B1 (en) | 1998-10-09 | 2005-12-27 | Gilead Sciences, Inc. | Non-homogeneous systems for the resolution of enantiomeric mixtures |
ATE315574T1 (de) | 1998-11-05 | 2006-02-15 | Centre Nat Rech Scient | Nukleoside mit anti-hepatitis b virus wirkung |
ATE254126T1 (de) | 1998-12-23 | 2003-11-15 | Shire Biochem Inc | Antivirale nukleosidanaloga |
CN1297281C (zh) | 1999-03-29 | 2007-01-31 | 希拉生物化学股份有限公司 | 治疗白血病的方法 |
US6653318B1 (en) * | 1999-07-21 | 2003-11-25 | Yale University | 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use |
DE60011637T2 (de) * | 1999-09-24 | 2004-11-11 | Shire Biochem Inc., Laval | Dioxolan nukleosidanalogen zur behandlung und vorbeugung von viralen infektionen |
WO2001032153A2 (en) * | 1999-11-04 | 2001-05-10 | Shire Biochem Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
EP1600451A3 (en) | 1999-11-12 | 2008-09-10 | Pharmasset, Inc. | Synthesis of 2'-deoxy-l-nucleosides |
US6436948B1 (en) | 2000-03-03 | 2002-08-20 | University Of Georgia Research Foundation Inc. | Method for the treatment of psoriasis and genital warts |
HUP0301363A2 (hu) * | 2000-10-13 | 2005-12-28 | Shire Biochem Inc. | Javított intercelluláris bejuttathatóságú dioxolán analógok |
CA2788498C (en) | 2001-03-01 | 2016-02-16 | Gilead Sciences, Inc. | Polymorphic and other crystalline forms of cis-ftc |
DE10335061B4 (de) * | 2003-07-31 | 2005-11-17 | Wacker-Chemie Gmbh | Verfahren zur Herstellung von OH-geschützten [4-(2,6-damino-9H-purin-9-yl)-1,3-dioxolan-2-yl]methanol-Derivaten |
US7785839B2 (en) | 2004-02-03 | 2010-08-31 | Emory University | Methods to manufacture 1,3-dioxolane nucleosides |
AU2006294807B2 (en) | 2005-09-26 | 2013-01-17 | Gilead Pharmasset Llc | Modified 4'-nucleosides as antiviral agents |
US8895531B2 (en) | 2006-03-23 | 2014-11-25 | Rfs Pharma Llc | 2′-fluoronucleoside phosphonates as antiviral agents |
ES2500165T3 (es) | 2006-06-29 | 2014-09-30 | Kinex Pharmaceuticals, Llc | Composiciones de biarilo y métodos para modular una cascada de quinasas |
WO2009051848A1 (en) | 2007-10-20 | 2009-04-23 | Kinex Pharmaceuticals, Llc | Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof |
US9675632B2 (en) | 2014-08-26 | 2017-06-13 | Enanta Pharmaceuticals, Inc. | Nucleoside and nucleotide derivatives |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL76546A (en) * | 1984-10-12 | 1988-12-30 | Warner Lambert Co | 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them |
ATE108794T1 (de) * | 1985-05-15 | 1994-08-15 | Wellcome Found | Therapeutische nucleoside und deren herstellung. |
-
1989
- 1989-04-07 NZ NZ228645A patent/NZ228645A/xx unknown
- 1989-04-10 DK DK198901720A patent/DK175372B1/da not_active IP Right Cessation
- 1989-04-10 IE IE113689A patent/IE71225B1/en not_active IP Right Cessation
- 1989-04-10 CA CA000596218A patent/CA1339609C/en not_active Expired - Lifetime
- 1989-04-11 IL IL89921A patent/IL89921A/xx unknown
- 1989-04-11 DE DE68924549T patent/DE68924549T2/de not_active Expired - Lifetime
- 1989-04-11 AT AT89303537T patent/ATE129247T1/de not_active IP Right Cessation
- 1989-04-11 AU AU32644/89A patent/AU631786B2/en not_active Expired
- 1989-04-11 EP EP89303537A patent/EP0337713B1/en not_active Expired - Lifetime
- 1989-04-11 ZA ZA892645A patent/ZA892645B/xx unknown
- 1989-04-11 JP JP01089893A patent/JP3085675B2/ja not_active Expired - Lifetime
- 1989-04-11 OA OA59557A patent/OA09470A/xx unknown
- 1989-04-11 ES ES89303537T patent/ES2078234T3/es not_active Expired - Lifetime
- 1989-04-11 KR KR1019890004725A patent/KR0137023B1/ko not_active IP Right Cessation
-
1995
- 1995-10-19 GR GR950401393T patent/GR3017812T3/el unknown
-
1996
- 1996-01-11 HK HK5996A patent/HK5996A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0337713A3 (en) | 1990-11-22 |
GR3017812T3 (en) | 1996-01-31 |
DK172089D0 (da) | 1989-04-10 |
NZ228645A (en) | 1991-09-25 |
OA09470A (en) | 1992-11-15 |
ATE129247T1 (de) | 1995-11-15 |
JPH01316375A (ja) | 1989-12-21 |
JP3085675B2 (ja) | 2000-09-11 |
IE891136L (en) | 1989-10-11 |
AU631786B2 (en) | 1992-12-10 |
HK5996A (en) | 1996-01-19 |
KR890016046A (ko) | 1989-11-28 |
DE68924549D1 (de) | 1995-11-23 |
IE71225B1 (en) | 1997-02-12 |
EP0337713B1 (en) | 1995-10-18 |
DK172089A (da) | 1989-10-12 |
IL89921A0 (en) | 1989-12-15 |
AU3264489A (en) | 1989-10-12 |
CA1339609C (en) | 1997-12-30 |
ES2078234T3 (es) | 1995-12-16 |
EP0337713A2 (en) | 1989-10-18 |
DE68924549T2 (de) | 1996-04-04 |
DK175372B1 (da) | 2004-09-13 |
IL89921A (en) | 1993-08-18 |
KR0137023B1 (ko) | 1998-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0337713A3 (en) | 2-substituted-4-substituted-1,3-dioxolanes, synthesis and use thereof | |
TR23424A (tr) | 1,2,3,6-tetrahidro-5-nitro-pirimidin tuerevleri | |
IT1212143B (it) | Composizione ad attivita'tricogena. | |
EP0406211A3 (en) | Fucosidase inhibitors | |
DK430689A (da) | 2-aza-4-(alkoxycarbonyl)spiro(4,5)decan-3-oner | |
PT91966A (pt) | Mesa de entrada dupla | |
EP0401262A4 (en) | 24r-scymnol, and preparation and use thereof | |
ES2023930B3 (es) | Sintesis de ditioles. | |
IE902286L (en) | Use of isoxazolin-3-one derivatives as antidepressants | |
KR930005225B1 (en) | Voice synthesizer | |
FI930300A0 (fi) | 5-Amino-1,2,4-tiadiatsol-3-yyli-iminokarbonyyliyhdiste | |
IE851525L (en) | Synthesis of 1,3-dioxanes | |
BR6700598U (pt) | Amuleto de mesa | |
IT8820405A0 (it) | Sintesi di trifluorometilisossazoli. | |
ES1024577Y (es) | Juego ciclista de mesa. | |
DE68925550D1 (de) | Krimpendstück | |
MTP981B (en) | "jigarounds",an educational jigsaw | |
TR22570A (tr) | Derinin seri olarak tabaklan masina mahsus usul | |
IT8819944A0 (it) | Sintesi elettrochimica di 2 arilidrochinoni. | |
SG2094G (en) | Beta-carbonyl-carboxyamides of 1,3-thiazolidines | |
BR6601010U (pt) | Bolsa porta-capacete | |
KR940000244U (ko) | 선반의 재치관 협지구 | |
KR890006542U (ko) | 산업용 로버트의 2단 핸드 멀티헤드 | |
BR8806084A (pt) | Mesa pantografica | |
IE861001L (en) | 1,3-dioxanes |